High fat diet exacerbates intestinal barrier dysfunction and changes gut microbiota in intestinal-specific ACF7 knockout mice

被引:27
|
作者
Shi, Chenzhang [1 ]
Li, Hao [1 ]
Qu, Xiao [1 ]
Huang, Linsheng [1 ]
Kong, Cheng [1 ]
Qin, Huanlong [1 ]
Sun, Zhenliang [1 ]
Yan, Xuebing [1 ,2 ]
机构
[1] Tongji Univ, Dept Gen Surg, Shanghai Peoples Hosp 10, 301 Yan Chang Rd, Shanghai 200072, Peoples R China
[2] Yangzhou Univ, Dept Oncol, Affiliated Hosp, 368 Han Jiang Rd, Yangzhou 225000, Jiangsu, Peoples R China
基金
中国博士后科学基金;
关键词
ACF7; Intestinal microbiology; Metabolism; High fat diet; Intestinal barrier function; INDUCED OBESITY; INFLAMMATION; DIVERSITY; MECHANISM; MIGRATION; LENGTH;
D O I
10.1016/j.biopha.2018.11.100
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Microtubule-actin cross-linking factor-1 (ACF7, or MACF1) regulates cytoskeletal focal adhesion dynamics and migration in various tissues. High fat diet (HFD) induces gut microbiota dysbiosis and metabolic disorders, and increases intestinal permeability and inflammatory response. Here we investigated the synergistic effects of intestinal ACF7 conditional knockout (ACF7 cKO) and HFD on metabolism phenotypes, gut microbiota and intestinal barrier function in mice. ACF7 cKO and control (ACF7fl/fl) mice (8-week-old) were fed with either chow diet or HFD, for 16 weeks. The increase of body weight and fat pad weight were impaired in HFD-fed ACF7 cKO mice, which can be attributed to decreased food intake and absorption. The metabolic status of HFD-fed ACF7 cKO mice was dramatically changed when compared to the other groups. In addition, HFD-fed ACF7 cKO mice had increased epithelial cell apoptosis, intestinal permeability and inflammatory response when compared with the other groups. The ACF7 cKO-induced changes in alimentation, intestinal barrier function, and gut microbiota were independent of dietary treatment. Taken together, our studies for the first time proved HFD and ACF7 cKO have synergistic damaging effects on intestinal homeostasis. ACF7 is a crucial protective molecule in HFD-induced intestinal diseases.
引用
收藏
页码:537 / 545
页数:9
相关论文
共 50 条
  • [21] Effect of High Sugar and High Fat Diet on Intestinal Barrier Function and Inflammation in Mice
    Shao J.
    Tian M.
    Wang F.
    Sun Y.
    Wang G.
    Ai L.
    Xia Y.
    Journal of Chinese Institute of Food Science and Technology, 2023, 23 (09) : 79 - 88
  • [22] Epicatechin and β-glucan from whole highland barley grain ameliorates hyperlipidemia associated with attenuating intestinal barrier dysfunction and modulating gut microbiota in high-fat-diet-fed mice
    Liu, Zehua
    Tang, Ruoxin
    Liu, Jianshen
    Zhang, Zhaowan
    Li, Yuanyuan
    Zhao, Renyong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [23] Chrysanthemum extract mitigates high-fat diet-induced inflammation, intestinal barrier damage and gut microbiota disorder
    Yuan, Yiwei
    Zhang, Yu
    Hu, Chunli
    Wang, Zhenyu
    Xu, Qianqian
    Pan, Ruili
    Li, Xiaojun
    Christian, Mark
    Zhu, Peinan
    Zhao, Jin
    FOOD & FUNCTION, 2025, 16 (04) : 1347 - 1359
  • [24] EFFECT OF BAICALIN ON THE INTESTINAL MICROBIOTA IN OBESE MICE INDUCED BY HIGH-FAT DIET
    Li, J. J.
    APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH, 2023, 21 (06): : 5941 - 5959
  • [25] HIGH-FAT DIET-INDUCED GUT MICROBIOTA DYSBIOSIS PROMOTE INTESTINAL CARCINOGENESIS
    Guo, Zixuan
    Liu, Tianyu
    Jiang, Kui
    Wang, Bangmao
    Cao, Hailong
    GASTROENTEROLOGY, 2019, 156 (06) : S685 - S685
  • [26] Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier
    Shu, Yan Yun
    Hu, Li Lin
    Ye, Jin
    Yang, Ling
    Jin, Yu
    LIFE SCIENCES, 2024, 357
  • [27] Lead exposure aggravates glucose metabolism disorders through gut microbiota dysbiosis and intestinal barrier damage in high-fat diet-fed mice
    Wang, Nana
    Gao, Xue
    Huo, Yuan
    Li, Yuting
    Cheng, Fangru
    Zhang, Zengli
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2024, 104 (05) : 3057 - 3068
  • [28] The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity
    Lau, Eva
    Marques, Claudia
    Pestana, Diogo
    Santoalha, Mariana
    Carvalho, Davide
    Freitas, Paula
    Calhau, Conceicao
    NUTRITION & METABOLISM, 2016, 13
  • [29] λ-carrageenan exacerbates Citrobacter rodentium-induced infectious colitis in mice by targeting gut microbiota and intestinal barrier integrity
    Wu, Wei
    Zhou, Dongsheng
    Xuan, Rongrong
    Zhou, Jiawei
    Liu, Jingwangwei
    Chen, Juanjuan
    Han, Hui
    Niu, Tingting
    Li, Xingxing
    Chen, Haimin
    Wang, Feng
    PHARMACOLOGICAL RESEARCH, 2021, 174
  • [30] The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity
    Eva Lau
    Cláudia Marques
    Diogo Pestana
    Mariana Santoalha
    Davide Carvalho
    Paula Freitas
    Conceição Calhau
    Nutrition & Metabolism, 13